Welcome
Support Centre
17 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Radical cure of vivax malaria
ISRCTN ISRCTN14027467
ClinicalTrials.gov identifier
Public title Radical cure of vivax malaria
Scientific title Open label comparison of Chloroquine (CQ) alone versus CQ plus 5 days unobserved Primaquine or CQ plus 14 days unobserved primaquine
Acronym CqPq
Serial number at source CP1
Study hypothesis Radical cure of vivax malaria requires 14 days primaquine. However a 5 day regimen has been widely recommended. This trial compares the two radical regimens versus no primaquine.
Lay summary Lay summary under review 4
Ethics approval 1. Calcultta School of Tropical Medicine approved in early 2003
2. Faculty of Tropical Medicne, Mahidol University approved on 8th December 2005, ref: TM-IRB056/2005
Study design Open label randomised comparison
Countries of recruitment India
Disease/condition/study domain Vivax malaria
Participants - inclusion criteria 1. Age > 3 years
2. Fully informed consent to long follow-up
3. Acute uncomplicated vivax malaria
4. Not pregnant
Participants - exclusion criteria 1. <3 years
2. Pregnancy
3. Severe disease
Anticipated start date 01/04/2003
Anticipated end date 01/09/2004
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 150
Interventions 1. Chloroquine (25mg base/kg total) only ; 10mg/kg on day 1, 10mg/kg on day 2 then 5mg/kg on day 3
2. Chloroquine (25mg base/kg total as above) followed by primaquine 0.25mg base/kg/day for 5 days-total dose 1.25mg base/kg (75mg in an adult)
3. Chloroquine (25mg base/kg total) followed by primaquine 0.25mg base/kg/ day for 14 days -total dose 3.5mg base/kg (210mg in an adult)
Primary outcome measure(s) Relapse rate
Secondary outcome measure(s) Adverse effects
Sources of funding Wellcome Trust (UK) (reference No. 066439/2/01/2)
Trial website
Publications
Contact name Prof  Nicholas  White
  Address MORU
Faculty of Tropical Medicine
Mahidol University
  City/town Bangkok
  Zip/Postcode 10400
  Country Thailand
  Tel +66 (0)2 203 6301
  Email nickw@tropmedres.ac
Sponsor Mahidol University (Thailand)
  Address Faculty of Tropical Medicine
420/6 Rajvithi Rd
  City/town Bangkok
  Zip/Postcode 10400
  Country Thailand
Date applied 12/11/2011
Last edited 01/05/2012
Date ISRCTN assigned 16/11/2011
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central